Publication Name	World Journal of Diabetes
Manuscript ID	76779
Country	Greece

Received	2022-03-30 11:13
Peer-Review Started	2022-03-30 11:14
To Make the First Decision
Return for Revision	2022-05-11 21:14
Revised	2022-05-23 19:47
Second Decision	2022-08-17 03:18
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief	2022-08-17 17:45
Articles in Press	2022-08-17 17:45
Publication Fee Transferred
Edit the Manuscript by Language Editor	2022-08-31 07:59
Typeset the Manuscript	2022-10-09 03:32
Publish the Manuscript Online	2022-10-14 08:30

ISSN	1948-9358 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Copyright	© The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Endocrinology & Metabolism
Manuscript Type	Editorial
Article Title	Considerations for the management of patients with diabetes mellitus and acute COVID-19
Manuscript Source	Invited Manuscript
All Author List	Efterpi Mougakou, Maria Kyziroglou, Alexandra Tsankof, Evangelos Cholongitas and Konstantinos Tziomalos
ORCID	Author(s) ORCID Number Efterpi Mougakou http://orcid.org/0000-0003-4255-5322 Maria Kyziroglou http://orcid.org/0000-0003-3247-4211 Evangelos Cholongitas http://orcid.org/0000-0002-3645-582X Konstantinos Tziomalos http://orcid.org/0000-0002-3172-1594
Funding Agency and Grant Number
Corresponding Author	Konstantinos Tziomalos, MD, MSc, PhD, Associate Professor, First Propedeutic Department of Internal Medicine, Medical School, Aristotle University of Thessaloniki, AHEPA Hospital, 1 Stilponos Kyriakidi Street, Thessaloniki 54636, Greece. ktziomalos@yahoo.com
Key Words	Diabetes mellitus; COVID-19; Insulin; Antidiabetic agents; Dexamethasone; Tocilizumab; Remdesivir
Core Tip	Diabetes mellitus is a frequent comorbidity in patients hospitalized with coronavirus disease 2019 and is associated with adverse outcomes. Strict glycemic control using insulin is necessary in most of these patients. Dexamethasone, antiviral agents and immunomodulation are also frequently administered and require vigilance and careful monitoring for adverse effects, particularly infections.
Publish Date	2022-10-14 08:30
Citation	Mougakou E, Kyziroglou M, Tsankof A, Cholongitas E, Tziomalos K. Considerations for the management of patients with diabetes mellitus and acute COVID-19. World J Diabetes 2022; 13(10): 802-808
URL	https://www.wjgnet.com/1948-9358/full/v13/i10/802.htm
DOI	https://dx.doi.org/10.4239/wjd.v13.i10.802

Full Article (PDF)	WJD-13-802.pdf
Full Article (Word)	WJD-13-802.docx
Manuscript File	76779_Auto_Edited-LM_WangTQ.docx
Answering Reviewers	76779-Answering reviewers.pdf
Audio Core Tip	76779-Audio core tip.aac
Conflict-of-Interest Disclosure Form	76779-Conflict-of-interest statement.pdf
Copyright License Agreement	76779-Copyright license agreement.pdf
Non-Native Speakers of English Editing Certificate	76779-Language certificate.pdf
Peer-review Report	76779-Peer-review(s).pdf
Scientific Misconduct Check	76779-Bing-Gao CC-2.png
Scientific Editor Work List	76779-Scientific editor work list.pdf
CrossCheck Report	76779-CrossCheck report.pdf